Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid beta-infused rats relates to the decreases of amyloid beta and cholesterol levels in detergent-insoluble membrane fractions.

We investigated the effects of dietary administration of docosahexaenoic acid (DHA; C22:6n-3) on the levels of amyloid beta (A beta) peptide (1-40) and cholesterol in the nonionic detergent Triton 100 x-insoluble membrane fractions (DIFs) of the cerebral cortex and, also, on learning-related memory in an animal model of Alzheimer's disease (AD) rats infused with A beta peptide (1-40) into the cerebral ventricle. The infusion increased the levels of A beta peptide and cholesterol in the DIFs concurrently with a significant increase in reference memory errors (measured by eight-arm radial-maze tasks) compared with those of vehicle rats. Conversely, the dietary administration of DHA to AD-model rats decreased the levels of A beta peptide and cholesterol in the DIFs, with the decrease being more prominent in the DHA-administered rats. Regression analysis revealed a significant positive correlation between A beta peptide and each of cholesterol, palmitic acid and stearic acid, and between the number of reference memory errors and each of cholesterol, palmitic, stearic and oleic acid; moreover, a significant negative correlation was observed between the number of reference memory errors and the molar ratio of DHA to palmitic plus stearic acid. These results suggest that DHA-induced protection of memory deficits in AD-model rats is related to the interactions of cholesterol, palmitic acid or stearic acid with A beta peptides in DIFs where DHA ameliorates these interactions.

[1]  D. Mostofsky,et al.  The role of polyunsaturated fatty acids in restoring the aging neuronal membrane , 2002, Neurobiology of Aging.

[2]  Yoshimi Fujii,et al.  Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. , 2005, The Journal of nutrition.

[3]  N. Cairns,et al.  Cholesterol Modulates the Membrane- Disordering Effects of Beta-Amyloid Peptides in the Hippocampus: Specific Changes in Alzheimer’s Disease , 2000, Dementia and Geriatric Cognitive Disorders.

[4]  W. Strittmatter,et al.  Transthyretin sequesters amyloid beta protein and prevents amyloid formation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Bennett,et al.  Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. , 2003, Archives of neurology.

[6]  A. D. Smith,et al.  The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. , 1984, Biochimica et biophysica acta.

[7]  H. Saito,et al.  Dietary Docosahexaenoic Acid Increases Cerebral Acetylcholine Levels and Improves Passive Avoidance Performance in Stroke-Prone Spontaneously Hypertensive Rats , 1997, Pharmacology Biochemistry and Behavior.

[8]  Takashi Morihara,et al.  Docosahexaenoic Acid Protects from Dendritic Pathology in an Alzheimer's Disease Mouse Model , 2004, Neuron.

[9]  J. Dichgans,et al.  Cholesterol and Alzheimer’s disease , 2001, Neurology.

[10]  Deborah A. Brown,et al.  Palmitoylation and Intracellular Domain Interactions Both Contribute to Raft Targeting of Linker for Activation of T Cells* , 2005, Journal of Biological Chemistry.

[11]  M. Roth,et al.  Role of Lipid Modifications in Targeting Proteins to Detergent-resistant Membrane Rafts , 1999, The Journal of Biological Chemistry.

[12]  S. Hossain,et al.  Chronic Administration Of Docosahexaenoic Acid Improves The Performance Of Radial Arm Maze Task In Aged Rats , 2001, Clinical and experimental pharmacology & physiology.

[13]  C. Behl,et al.  Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach. , 2002, Free radical biology & medicine.

[14]  M. Tierney,et al.  Fatty acid analysis of blood plasma of patients with alzheimer's disease, other types of dementia, and cognitive impairment , 2000, Lipids.

[15]  M. Hossain,et al.  Effects of eicosapentaenoic acid and docosahexaenoic acid on plasma membrane fluidity of aortic endothelial cells , 1999, Lipids.

[16]  C. Haass,et al.  Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts , 2003, The Journal of cell biology.

[17]  Endo Akira,et al.  Inhibition of in vitro cholesterol synthesis by fatty acids. , 1977 .

[18]  T. Hasegawa,et al.  Continuous infusion of beta-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration. , 1998, Japanese journal of pharmacology.

[19]  T. Beach,et al.  Reduction of cortical amyloid β levels in guinea pig brain after systemic administration of physostigmine , 2001, Neuroscience Letters.

[20]  C. Bergmann,et al.  Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[21]  T. Hara,et al.  Improvement of spatial cognition with dietary docosahexaenoic acid is associated with an increase in Fos expression in rat CA1 hippocampus , 2004, Clinical and experimental pharmacology & physiology.

[22]  E. Lai.  Lipid rafts make for slippery platforms , 2003, The Journal of cell biology.

[23]  Giancarlo V. De Ferrari and,et al.  Wnt signaling function in Alzheimer’s disease , 2000, Brain Research Reviews.

[24]  L. Frøyland,et al.  Chronic administration of eicosapentaenoic acid and docosahexaenoic acid as ethyl esters reduced plasma cholesterol and changed the fatty acid composition in rat blood and organs , 1996, Lipids.

[25]  K. Kristensson,et al.  Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease , 1991, Lipids.

[26]  T. Nabeshima,et al.  Impairments of long-term potentiation in hippocampal slices of beta-amyloid-infused rats. , 1999, European journal of pharmacology.

[27]  Deborah A. Brown,et al.  Structure and Function of Sphingolipid- and Cholesterol-rich Membrane Rafts* , 2000, The Journal of Biological Chemistry.

[28]  M. S. Clarke,et al.  Plasma membrane ordering agent pluronic F-68 (PF-68) reduces neurotransmitter uptake and release and produces learning and memory deficits in rats. , 1999, Learning & memory.

[29]  C. Dotti,et al.  The conflicting role of brain cholesterol in Alzheimer's disease: lessons from the brain plasminogen system. , 2005, Biochemical Society symposium.

[30]  M. Hossain,et al.  Antioxidative Effects of Docosahexaenoic Acid in the Cerebrum Versus Cerebellum and Brainstem of Aged Hypercholesterolemic Rats , 1999, Journal of neurochemistry.

[31]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[32]  Y. Ihara,et al.  The presence of amyloid beta-protein in the detergent-insoluble membrane compartment of human neuroblastoma cells. , 1998, Biochemistry.

[33]  S. Mumby.  Reversible palmitoylation of signaling proteins. , 1997, Current opinion in cell biology.

[34]  Y. Ishibashi,et al.  Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats , 2002, Journal of neurochemistry.

[35]  J. Joseph,et al.  Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging , 1995, Trends in Neurosciences.

[36]  W. G. Wood,et al.  Cholesterol modulates amyloid beta-peptide's membrane interactions. , 2003, Pharmacopsychiatry.

[37]  R. Friedland,et al.  Nicotine inhibits amyloid formation by the beta-peptide. , 1996, Biochemistry.

[38]  P. Green,et al.  Intraamniotic Ethyl Docosahexaenoate Administration Protects Fetal Rat Brain from Ischemic Stress , 1998, Journal of neurochemistry.

[39]  K. Sugioka,et al.  Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats , 1999, Neuroscience.

[40]  J McLaurin,et al.  Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis and neurotoxicity. , 2001, Journal of molecular biology.

[41]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[42]  E. Perry,et al.  Chronic nicotine treatment reduces β‐amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw) , 2002, Journal of neurochemistry.

[43]  M. Weber,et al.  Alterations in lipid acyl group composition and membrane structure in cells transformed by Rous sarcoma virus. , 1976, Biochemistry.

[44]  L. Herbette,et al.  Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol , 1992, Neurobiology of Aging.

[45]  M. Hossain,et al.  Association of age-related decrease in platelet membrane fluidity with platelet lipid peroxide. , 1998, Life sciences.

[46]  O. Shido,et al.  Synaptic plasma membrane-bound acetylcholinesterase activity is not affected by docosahexaenoic acid-induced decrease in membrane order. , 2004, Life sciences.

[47]  A. Buczyński,et al.  Changes in antioxidant enzymes activities, aggregability and malonyldialdehyde concentration in blood platelets from patients with coronary heart disease. , 1993, Atherosclerosis.

[48]  Alexander D. MacKerell,et al.  Molecular-level organization of saturated and polyunsaturated fatty acids in a phosphatidylcholine bilayer containing cholesterol. , 2004, Biochemistry.

[49]  P. Yeagle.  Cholesterol and the cell membrane. , 1985, Biochimica et biophysica acta.

[50]  G. Lepage,et al.  Specific methylation of plasma nonesterified fatty acids in a one-step reaction. , 1988, Journal of Lipid Research.

[51]  H Jick,et al.  Statins and the risk of dementia , 2000, The Lancet.

[52]  P. Mcgeer,et al.  3-Hydroxy-3-methylglutaryl-coenzyme A reductase mRNA in Alzheimer and control brain , 2001, Neuroreport.

[53]  W. Müller,et al.  β-amyloid peptide decreases membrane fluidity , 1995, Brain Research.

[54]  M. Matsuo,et al.  Oxidative injury of synapse and alteration of antioxidative defense systems in rats, and its prevention by vitamin E. , 1997, European journal of biochemistry.

[55]  Yoshimi Fujii,et al.  Effects of docosahexaenoic acid on annular lipid fluidity of the rat bile canalicular plasma membrane. , 2001, Journal of lipid research.

[56]  Takashi Morihara,et al.  A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model , 2005, The Journal of Neuroscience.

[57]  D. C. Mitchell,et al.  Effect of cholesterol on molecular order and dynamics in highly polyunsaturated phospholipid bilayers. , 1998, Biophysical journal.

[58]  D. Butterfield,et al.  Electron spin resonance studies of fatty acid-induced alterations in membrane fluidity in cultured endothelial cells. , 1995, The international journal of biochemistry & cell biology.

[59]  G. Celesia,et al.  Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. , 2000, Archives of neurology.

[60]  D. Selkoe,et al.  The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease , 1998 .

[61]  G. Barceló-Coblijn,et al.  Short-term administration of omega 3 fatty acids from fish oil results in increased transthyretin transcription in old rat hippocampus , 2003, Proceedings of the National Academy of Sciences of the United States of America.